TYK2 and rheumatoid arthritis: Similarly, anti-TNFα therapy has been shown to reverse compromised Treg function in rheumatoid arthritis [38], and tyrosine kinase 2 (TYK2) inhibitors might prove superior to Janus kinase 1 (JAK1) inhibitors in the treatment of PsoA regarding Treg function [39].